Medpace CEO and President August J. Troendle Sells Over $30M in Stock

August J. Troendle, a 10% owner, President & CEO of Medpace, sold common stock in two transactions on September 29 and 30, 2026. The total sale amount was $30,320,929, with weighted average prices of $621.02 and $625.47 per share.